Register Login

CANDEL THERAPEUTICS, INC. (CADL)

(90% Positive) CANDEL THERAPEUTICS, INC. (CADL) Announces Enrollment Update for enrollment Due to Patient Enrollment Issues, Regulatory Process, Manufacturing Considerations, Safety Review

Full text
Register to leave comments
  • News bot Aug. 13, 2026, 12:36 p.m.

    📋 CANDEL THERAPEUTICS, INC. (CADL) - Clinical Trial Update

    Filing Date: 2026-08-13

    Accepted: 2026-08-13 08:15:15

    Event Type: Clinical Trial Update

    Event Details:

    CANDEL THERAPEUTICS, INC. (CADL) Announces Clinical Trial Update CANDEL THERAPEUTICS, INC. (CADL) provided an update on its clinical development programs. Clinical Development Highlights:
    • Drug Program: enrollment, alone
    • Diseases/Conditions: a global pivotal phase 3 clinical trial (AURORA)
    • Clinical Stage: phase 3, clinical trial
    • Collaboration: AURORA
      • planned for Q4 2026

    🔬 Clinical Development Pipeline (CANDEL THERAPEUTICS, INC.):

    Product Type Development Stage Therapeutic Area Source
    Aglatimagene Besadenovec Other Phase PHASE3 Non-squamous, Non-Small Cell Lung Cancer ClinicalTrials.gov
    Valacyclovir Other Phase PHASE3 Non-squamous, Non-Small Cell Lung Cancer ClinicalTrials.gov
    Usual treatment Drug Approved Major Abdominal Surgery ClinicalTrials.gov
    placebo Other Phase PHASE2 Prostate Cancer ClinicalTrials.gov
    Surgery Procedure Phase PHASE2 Borderline Resectable Pancreatic Adenocarcinoma ClinicalTrials.gov
    Stereotactic body radiation therapy Drug Phase PHASE2 Borderline Resectable Pancreatic Adenocarcinoma ClinicalTrials.gov
    Aglatimagene besadenovec Other Phase PHASE2 Borderline Resectable Pancreatic Adenocarcinoma ClinicalTrials.gov
    Docetaxel Other Phase PHASE3 Non-squamous, Non-Small Cell Lung Cancer ClinicalTrials.gov
    Pembrolizumab Other Phase PHASE3 Non-squamous, Non-Small Cell Lung Cancer ClinicalTrials.gov
    1450nm diode laser Other Preclinical Acne ClinicalTrials.gov
    Mycophenolic Acid + prednison Other Phase PHASE3 Lupus Nephritis ClinicalTrials.gov
    cyclosporine +mycophenolic acid+prednison Other Phase PHASE3 Lupus Nephritis ClinicalTrials.gov
    Predictors of health care provide Other Preclinical Covid19 ClinicalTrials.gov
    Predictors adverse evolution Other Preclinical Covid19 ClinicalTrials.gov
    CAN-2409 + valacyclovir Other Phase PHASE1 Lung Cancer ClinicalTrials.gov
    Hemodynamic monitoring Other Approved Major Abdominal Surgery ClinicalTrials.gov
    Piperacillin-Tazobactam intermittent infusion Other Phase PHASE3 Pseudomonas Aeruginosa Infection ClinicalTrials.gov
    Piperacillin-Tazobactam continuous infusion Other Phase PHASE3 Pseudomonas Aeruginosa Infection ClinicalTrials.gov
    1210nm Diode Laser treatments Drug Approved Axillary Hyperhidrosis ClinicalTrials.gov
    UltraShape Power Other Approved Circumference Reduction ClinicalTrials.gov
    Conventional FiO2 Other Approved Hyperoxia ClinicalTrials.gov
    High FiO2 Other Approved Hyperoxia ClinicalTrials.gov
    Dermal Handpiece / SubQ Handpiece Other Approved Skin Laxity ClinicalTrials.gov
    CO2RE fractional laser therapy Drug Approved Dyspareunia ClinicalTrials.gov
    4% Topical Lidocaine Gel Other Approved Dyspareunia ClinicalTrials.gov
    Laser hair removal Other Approved Pilonidal Disease ClinicalTrials.gov
    The CO2RE® System Other Approved Vulvar Lichen Sclerosus ClinicalTrials.gov
    1064 nm Nd:YAG laser Other Approved Localized Lipodystrophy ClinicalTrials.gov
    Combined Bipolar Radiofrequency&Pulsed Dye Laser Other Approved Port-Wine Stain ClinicalTrials.gov
    Pulsed Dye Laser Other Approved Port-Wine Stain ClinicalTrials.gov
    GentleMax Pro Plus 755nm and 1064nm laser system Other Approved Unwanted Fine Facial Hair ClinicalTrials.gov
    Nonablative Fractional Diode Laser Other Approved Skin Texture ClinicalTrials.gov
    FRAX 1940 nm laser Other Approved Pigmented Skin Lesion ClinicalTrials.gov
    AdV-tk + valacyclovir Other Phase PHASE1 Malignant Pleural Effusion ClinicalTrials.gov
    Dietary supplement Other Preclinical Malnutrition ClinicalTrials.gov
    Conventional endotracheal tube Other Approved Laryngeal Injury ClinicalTrials.gov
    Triglotix® Other Approved Laryngeal Injury ClinicalTrials.gov
    GentleMax Pro Plus Other Approved Pseudofolliculitis Barbae ClinicalTrials.gov
    PicoWay™ 1064nm fractional handpiece Other Approved Benign Pigmented Lesions ClinicalTrials.gov
    PicoWay™ 730nm wavelength Other Approved Benign Pigmented Lesions ClinicalTrials.gov
    PicoWay™ 532nm fractional handpiece Other Approved Benign Pigmented Lesions ClinicalTrials.gov
    Chemoradiation Other Phase PHASE2 Borderline Resectable Pancreatic Adenocarcinoma ClinicalTrials.gov
    Profound Matrix Other Preclinical Wrinkle ClinicalTrials.gov
    Profound Matrix™ System Other Approved Wrinkle ClinicalTrials.gov
    Laboratory Biomarker Analysis Other Phase PHASE1 Glioma, Malignant ClinicalTrials.gov
    Nivolumab Other Phase PHASE1 Glioma, Malignant ClinicalTrials.gov
    Temozolomide Other Phase PHASE1 Glioma, Malignant ClinicalTrials.gov
    Radiation Other Phase PHASE1 Glioma, Malignant ClinicalTrials.gov
    AdV-tk Other Phase PHASE1 Glioma, Malignant ClinicalTrials.gov
    Pain assessment using a behavioral scale Other Preclinical Pain ClinicalTrials.gov
    Placebo + valacyclovir Other Phase PHASE3 Prostate Cancer ClinicalTrials.gov
    Aglatimagene besadenovec + valacyclovir Other Phase PHASE3 Prostate Cancer ClinicalTrials.gov
    Nordlys, Gentle, Picoway, Vbeam, Profound, Profound Matrix, eTwo, Exceed, CO2RE Other Approved Hair Reduction ClinicalTrials.gov
    Sham Nordlys SWT IPL Other Approved Meibomian Gland Dysfunction ClinicalTrials.gov
    Meibomian Gland Expression (MGX) Other Approved Meibomian Gland Dysfunction ClinicalTrials.gov
    Nordlys SWT IPL Other Approved Meibomian Gland Dysfunction ClinicalTrials.gov
    Patient Registry Other Preclinical Myotonic Dystrophy 1 ClinicalTrials.gov
    Stereotactic biopsy Other Phase PHASE1 Malignant Glioma of Brain ClinicalTrials.gov
    Cyclophosphamide Other Phase PHASE1 Malignant Glioma of Brain ClinicalTrials.gov
    rQNestin Other Phase PHASE1 Malignant Glioma of Brain ClinicalTrials.gov
    External Beam Radiation Therapy (EBRT) Drug Phase PHASE2 Prostate Cancer Patients Treated by Radiotherapy ClinicalTrials.gov
    Radiation therapy RADIATION Phase PHASE2 Malignant Glioma ClinicalTrials.gov
    CAN-2409 BIOLOGICAL Phase PHASE2 Malignant Glioma ClinicalTrials.gov

    💼 Business Developments:

    • Partnership
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: CANDEL THERAPEUTICS, INC.
    • Ticker Symbol: CADL

Search

News categories